Beta cell function pathways

The term "Beta cell function pathways" is not the name of a specific molecule, receptor, enzyme, or well-defined therapeutic target. Instead, it refers to a collection of complex molecular and signaling pathways that regulate the function, survival, differentiation, and insulin secretion activity of pancreatic beta cells. These pathways include G protein-coupled receptor (GPCR) signaling (such as those mediated by the glucagon-like peptide-1 receptor and others), receptors with enzymatic activity (like the TGF-β receptor family), oxidative stress responses, autophagy-related mechanisms, and various intracellular signaling networks (e.g., the JNK-Akt-FOXO1-PDX1 axis)[1][2][3][4]. Beta cell dysfunction—resulting from disruption in one or more of these pathways—is a central feature in both type 1 and type 2 diabetes, contributing to loss of insulin production and action[2][4]. Drug discovery typically focuses on specific proteins or molecular targets within these pathways, not on the pathways as a whole. Thus, “Beta cell function pathways” is too broad and not itself considered a discrete, druggable target, but rather describes the interrelated molecular biology underpinning beta cell health and disease[1][2][3].